CORE
CO
nnecting
RE
positories
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Research partnership
About
About
About us
Our mission
Team
Blog
FAQs
Contact us
Community governance
Governance
Advisory Board
Board of supporters
Research network
Innovations
Our research
Labs
Drugs That Interrupt the Renin-Angiotensin System Should Be Among the Preferred Initial Drugs to Treat Hypertension
Authors
Aberg
ALLHAT officers and coordinators for the ALLHAT Collaborative Research Group
+78 more
Baruch
Baruch
Biollaz
Black
Bloom
Brenner
Brown
Chobanian
Chrysant
Cifkova
Tognoni G, and Val-HeFT Investigators Cohn J
Conlin
Conlin
Cottone
Crozier
Dahloff
Dahloft
Kjekshus J, and the OPTIMAAL Steering Committee of the OPTIMAAL Study Group Dickstein K
Dzau
Franse
Gavras
Gavras H, and The Eprosartan Study Group Gavras I
Giatras
Goldberg
Gottdiener
Gottlieb
Granger
Gremmler
Grimm
Hansson
Hansson
Heras
Hjalmarson
Kaplan
Kaplan
Kochar
Konstam
Lang
Lebrillant
Levy
Lewis
Lewis
MacKay
Makris
Maschio
McInnes
McKelvie
Moore
Moore
Moser
Moser
Neldam
Oparil
Paran
Parker
Peters
Phelps
Pitt
Pitt
Plat
Reams
Rutherford
Schiffrin
Schiffrin
Sebastian
Soffer
Svensson
The Heart Outcomes Prevention Evaluation Study Investigators
Tonkon
Torp-Pedersen
Toto
US Renal Data System
Vasan
Veterans Administration Study Group
Veterans Administrative Cooperative Study Group
Vidal
Waeber
Yoshimuira
Publication date
Publisher
'Wiley'
Doi
Abstract
Abstract is not available.
Similar works
Full text
Available Versions
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
Last time updated on 11/12/2020
